Maxcyte, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
MXCT on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
9713 Key West Avenue,, Suite 400, Rockville, MD

Insiders trading volume in the past year

Maxcyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Casdin Partners Master Fund, L.P. 10%+ Owner $45.3M Oct 3, 2022
Art Mandell Director $1.94M Jun 11, 2024
Douglas Doerfler President and CEO, Director $1.51M Dec 4, 2023
Stanley C. Erck Director $1M -$548K -35.4% Nov 1, 2024
Douglas Richard Director $595K Jun 11, 2024
John Joseph Johnston Director $538K -$194K -26.5% Dec 6, 2024
J. Stark Thompson Phd Director $502K Aug 9, 2021
Maher Masoud President and CEO, Director $490K +$489K +47298% Jun 7, 2024
Douglas Swirsky Chief Financial Officer $374K Mar 15, 2024
William W. Brooke Director $351K Jun 11, 2024
David I. Sandoval General Counsel $211K Mar 15, 2024
Cynthia Collins Director $192K Oct 14, 2024
Thomas M. Ross Evp, Global Sales $109K -$419K -79.4% Aug 1, 2024
Yasir B. Al-Wakeel Director $105K Jun 11, 2024
Patrick J. Balthrop Director $105K Jun 11, 2024
Rekha Hemrajani Director $105K Jun 11, 2024
Ali Soleymannezhad Chief Commercial Officer $103K Sep 16, 2024
Cenk Sumen Chief Scientific Officer Apr 11, 2022
Amanda Louise Murphy Chief Financial Officer Mar 25, 2022
Ron Holtz Chief Financial Officer Mar 20, 2023

Recent Insider Transactions by Companies or Individuals for Maxcyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.